• A A A
  • Not a member yet?

    friend, discuss, blog, shop, sell, ask

    Sign up instantly!

    Learn about member benefits


    Unlike FDA, British Regulators Take Avandia off the Market

    Posted by

    Ending years of contoversy about the diabetes drug Avandia, the European Medicines Agency today took the step of stopping further use of the drug. An action teh U.S. FDA failed to take.

    The European Medicines Agency (EMA) “recommended the suspension of the marketing authorisations for the rosiglitazone-containing anti-diabetes medicines Avandia, Avandamet and Avaglim. These medicines will stop being available in Europe within the next few months.”, said a press release issued by the agency.

    Avandia came on the market in 1999 and is used by millions of people around the world. Questions about its safety began to surface in 2007 as studies linked the drug risk of heart attack or stroke.

    “The availability of recent studies has added to the knowledge about rosiglitazone and overall, the accumulated data support an increased cardiovascular risk of rosiglitazone. In view of the restrictions already in place on the use of rosiglitazone, the Committee could not identify additional measures that would reduce the cardiovascular risk. The Committee therefore concluded that the benefits of rosiglitazone no longer outweigh its risks and recommended the suspension of the marketing authorisation of the medicines.”, said the press release form the EMA

    European Medicines Agency

    Add a comment

    You must be logged in to comment.

    Ad not found